Judith Neukirchen

1.3k total citations
26 papers, 659 citations indexed

About

Judith Neukirchen is a scholar working on Hematology, Genetics and Emergency Medicine. According to data from OpenAlex, Judith Neukirchen has authored 26 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Genetics and 6 papers in Emergency Medicine. Recurrent topics in Judith Neukirchen's work include Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Hematological disorders and diagnostics (6 papers). Judith Neukirchen is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Hematological disorders and diagnostics (6 papers). Judith Neukirchen collaborates with scholars based in Germany, Switzerland and United States. Judith Neukirchen's co-authors include Rainer Haas, Corinna Strupp, Ulrich Germing, Norbert Gattermann, Carlo Aul, Ulrich Germing, Andrea Kündgen, Norbert Gattermann, W. Marieke Schoonen and Kathrin Nachtkamp and has published in prestigious journals such as Blood, Cancer and Journal of Translational Medicine.

In The Last Decade

Judith Neukirchen

24 papers receiving 652 citations

Peers

Judith Neukirchen
Arjan van de Loosdrecht Netherlands
Tiejun Qin China
Ilaria Ambaglio Italy
Xiaosha Zhang United States
Nils Mauritzson Sweden
Kerstin Görlich Germany
Maria de Lourdes Chauffaille Brazil
Carlos Hader United States
MR Baer United States
Albert Pérez-Ladaga Spain
Arjan van de Loosdrecht Netherlands
Judith Neukirchen
Citations per year, relative to Judith Neukirchen Judith Neukirchen (= 1×) peers Arjan van de Loosdrecht

Countries citing papers authored by Judith Neukirchen

Since Specialization
Citations

This map shows the geographic impact of Judith Neukirchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Neukirchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Neukirchen more than expected).

Fields of papers citing papers by Judith Neukirchen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Neukirchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Neukirchen. The network helps show where Judith Neukirchen may publish in the future.

Co-authorship network of co-authors of Judith Neukirchen

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Neukirchen. A scholar is included among the top collaborators of Judith Neukirchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Neukirchen. Judith Neukirchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neukirchen, Judith, Andrea Kuendgen, Norbert Gattermann, et al.. (2017). A retrospective study evaluating the impact of infectious complications during azacitidine treatment. Annals of Hematology. 96(7). 1097–1104. 12 indexed citations
2.
3.
Neukirchen, Judith, Kathrin Nachtkamp, Carlo Aul, et al.. (2015). Change of prognosis of patients with myelodysplastic syndromes during the last 30 years. Leukemia Research. 39(7). 679–683. 11 indexed citations
4.
5.
Schuler, Esther, M. Schroeder, Judith Neukirchen, et al.. (2014). Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias. Leukemia Research. 38(12). 1413–1419. 51 indexed citations
6.
Zipperer, E., Corinna Strupp, Andrea Kündgen, et al.. (2014). The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system. Haematologica. 99(3). e31–e32. 25 indexed citations
7.
Neukirchen, Judith, Michael Lauseker, Sabine Blum, et al.. (2013). Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study. Leukemia Research. 38(1). 57–64. 46 indexed citations
8.
Neukirchen, Judith, et al.. (2013). Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow. Annals of Hematology. 93(1). 65–69. 7 indexed citations
9.
Pfeilstöcker, Michael, Heinz Tüchler, Thomas Nösslinger, et al.. (2013). P-111 Time changes in predictive power of MDS prognostic scores – Effects on revised scores such as the IPSS-R, impact of age. Leukemia Research. 37. S73–S73. 1 indexed citations
10.
Neukirchen, Judith, Frank Fox, Andrea Kündgen, et al.. (2012). Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry. Leukemia Research. 36(8). 1067–1070. 99 indexed citations
11.
Neukirchen, Judith, W. Marieke Schoonen, Corinna Strupp, et al.. (2011). Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry. Leukemia Research. 35(12). 1591–1596. 138 indexed citations
12.
Kuendgen, A., Gesine Bug, Oliver G. Ottmann, et al.. (2011). Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid. Clinical Epigenetics. 2(2). 389–399. 29 indexed citations
13.
Neukirchen, Judith, Barbara Hildebrandt, A. Kuendgen, et al.. (2011). 312 Restratification of IPSS risk groups according to the WPSS identifies patients with myelodysplastic syndromes (MDS) at higher risk. Leukemia Research. 35. S124–S124. 1 indexed citations
14.
Neukirchen, Judith, Sabine Blum, Andrea Kuendgen, et al.. (2009). Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes. European Journal Of Haematology. 83(5). 477–482. 48 indexed citations
15.
Neukirchen, Judith, Rainer Haas, & Ulrich Germing. (2009). Prognostic molecular markers in myelodysplastic syndromes. Expert Review of Hematology. 2(5). 563–575. 1 indexed citations
16.
Neukirchen, Judith, W. Marieke Schoonen, Carlo Aul, et al.. (2009). Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005.. Blood. 114(22). 1774–1774. 3 indexed citations
17.
Rohrbeck, Astrid, Judith Neukirchen, Helene Geddert, et al.. (2008). Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. Journal of Translational Medicine. 6(1). 69–69. 56 indexed citations
18.
Neukirchen, Judith, Astrid Rohrbeck, Ulrich Steidl, et al.. (2007). The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells. Cancer Gene Therapy. 14(4). 431–439. 16 indexed citations
19.
Geddert, Helene, Astrid Rohrbeck, Guillermo García, et al.. (2006). The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.. Journal of Carcinogenesis. 5(1). 4–4. 29 indexed citations
20.
Heyd, Florian, Judith Neukirchen, Iris Queitsch, et al.. (2005). Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles. Journal of Virological Methods. 127(1). 40–45. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arjan van de Loosdrecht Breakdown of academic impact, for papers by Tiejun Qin Breakdown of academic impact, for papers by Ilaria Ambaglio Breakdown of academic impact, for papers by Xiaosha Zhang Breakdown of academic impact, for papers by Nils Mauritzson Breakdown of academic impact, for papers by Kerstin Görlich Breakdown of academic impact, for papers by Maria de Lourdes Chauffaille Breakdown of academic impact, for papers by Carlos Hader Breakdown of academic impact, for papers by MR Baer Breakdown of academic impact, for papers by Albert Pérez-Ladaga
Rankless by CCL
2026